Literature DB >> 16715687

Multi-centre, double blind, randomized trial of three steroid regimens in the treatment of type-1 reactions in leprosy.

P S S Sundar Rao1, D S T Sugamaran, J Richard, W C S Smith.   

Abstract

OBJECTIVE: The objective of this randomized trial was to compare three different steroid regimens in treating type 1 reactions in leprosy in routine clinical practice.
DESIGN: The study design was a multicentre, double-blind, randomized, controlled, parallel group trial in patients with acute reversal reactions. The trial was conducted in six leprosy treatment centres in India. A total of 334 participants with acute type 1 reaction were recruited to the trial and randomized to one of three prednisolone regimens: high dose (60 mg per day) or low dose (30 mg per day) both tapered over 20 weeks, and short duration (60 mg per day tapered over 12 weeks). The main outcome measure was the proportion of patients failing to respond to treatment and requiring additional steroids.
RESULTS: At the end of 12 months, 46% on the short course required additional steroids compared with 31% on the low dose and 24% on the high dose regimen.
CONCLUSIONS: The two 20-week regimens were significantly better than the 12-week regimen. The high dose 20-week regimen was marginally and non-significantly better than the low dose regimen, but the high dose regimen contained 50% more steroid. Reactions in leprosy persist over many months and require long courses of steroids.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16715687

Source DB:  PubMed          Journal:  Lepr Rev        ISSN: 0305-7518            Impact factor:   0.537


  11 in total

1.  Evolution of vision reducing cataract in skin smear positive lepromatous patients: does it have an inflammatory basis?

Authors:  Ebenezer Daniel; P S S Sundar Rao
Journal:  Br J Ophthalmol       Date:  2007-02-14       Impact factor: 4.638

2.  Predicting neuropathy and reactions in leprosy at diagnosis and before incident events-results from the INFIR cohort study.

Authors:  W Cairns S Smith; Peter G Nicholls; Loretta Das; Pramila Barkataki; Sujai Suneetha; Lavanya Suneetha; Rupendra Jadhav; P S S Sundar Rao; Einar P Wilder-Smith; Diana N J Lockwood; Wim H van Brakel
Journal:  PLoS Negl Trop Dis       Date:  2009-08-11

3.  A phase two randomised controlled double blind trial of high dose intravenous methylprednisolone and oral prednisolone versus intravenous normal saline and oral prednisolone in individuals with leprosy type 1 reactions and/or nerve function impairment.

Authors:  Stephen L Walker; Peter G Nicholls; Sushmita Dhakal; Rachel A Hawksworth; Murdo Macdonald; Kishori Mahat; Shudan Ruchal; Sushma Hamal; Deanna A Hagge; Kapil D Neupane; Diana N J Lockwood
Journal:  PLoS Negl Trop Dis       Date:  2011-04-12

4.  AZALEP a randomized controlled trial of azathioprine to treat leprosy nerve damage and Type 1 reactions in India: Main findings.

Authors:  Diana N J Lockwood; Joydeepa Darlong; Pitchaimani Govindharaj; Royce Kurian; Pamidipani Sundarrao; Annamma S John
Journal:  PLoS Negl Trop Dis       Date:  2017-03-30

5.  Late-onset ulnar neuritis following treatment of lepromatous leprosy infection.

Authors:  Trevor Wellington; Christina Schofield
Journal:  PLoS Negl Trop Dis       Date:  2019-08-19

Review 6.  Treatment and Evaluation Advances in Leprosy Neuropathy.

Authors:  Gigi J Ebenezer; David M Scollard
Journal:  Neurotherapeutics       Date:  2021-11-19       Impact factor: 7.620

7.  Two randomized controlled clinical trials to study the effectiveness of prednisolone treatment in preventing and restoring clinical nerve function loss in leprosy: the TENLEP study protocols.

Authors:  Inge Wagenaar; Wim Brandsma; Erik Post; Wim van Brakel; Diana Lockwood; Peter Nicholls; Paul Saunderson; Cairns Smith; Einar Wilder-Smith; Jan Hendrik Richardus
Journal:  BMC Neurol       Date:  2012-12-18       Impact factor: 2.474

8.  Diagnosis and treatment of leprosy reactions in integrated services--the patients' perspective in Nepal.

Authors:  Sonia F Raffe; Min Thapa; Saraswoti Khadge; Krishna Tamang; Deanna Hagge; Diana N J Lockwood
Journal:  PLoS Negl Trop Dis       Date:  2013-03-07

9.  A Randomized Controlled Double Blind Trial of Ciclosporin versus Prednisolone in the Management of Leprosy Patients with New Type 1 Reaction, in Ethiopia.

Authors:  Saba M Lambert; Digafe T Alembo; Shimelis D Nigusse; Lawrence K Yamuah; Stephen L Walker; Diana N J Lockwood
Journal:  PLoS Negl Trop Dis       Date:  2016-04-05

10.  Effectiveness of 32 versus 20 weeks of prednisolone in leprosy patients with recent nerve function impairment: A randomized controlled trial.

Authors:  Inge Wagenaar; Erik Post; Wim Brandsma; Bob Bowers; Khorshed Alam; Vanaja Shetty; Vivek Pai; Sajid Husain; Cita Rosita Sigit Prakoeswa; Linda Astari; Deanna Hagge; Mahesh Shah; Kapil Neupane; Krishna Bahadur Tamang; Peter Nicholls; Jan Hendrik Richardus
Journal:  PLoS Negl Trop Dis       Date:  2017-10-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.